| Typicality: | 0.282 |
| Saliency: | 0.280 |
| by directors | 34 | other |
| at first bancorp | 5 | location |
| at spectrum pharmaceuticals | 4 | location |
| investigation → be announced over → potential breaches of fiduciary duties | 17 |
| negative | neutral | positive |
| 0.514 | 0.472 | 0.014 |
| Raw frequency | 17 |
| Normalized frequency | 0.280 |
| Modifier score | 0.500 |
| Perplexity | 30.195 |